Augmentation of resistance of mice to bacterial infection by a polysaccharide-peptidoglycan complex (PSPG) extracted fromLactobacillus casei
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
A water-soluble polysaccharide-peptidoglycan complex (PSPG) was prepared from heat-killedLactobacillus casei by digesting the bacteria with N-acetylmuramidase. The molecular weight of PSPG was over 30,000, and the polysaccharide portion of PSPG, its main component was composed of rhamnose, glucose, galactose, glucosamine and galactosamine. Mice pretreated intraperitoneally with PSPG survived after a lethal infection withListeria monocytogenes orPseudomonas aeruginosa. The growth of infecting bacteria (L. monocytogenes, P. aeruginosa, Salmonella typhimurium, Escherichia coli) in both the peritoneal cavity and the liver was inhibited markedly in the mice that had been treated with PSPG. It was suggested that macrophages may be the main effector for the anti-infectious effect of PSPG since treatment of mice with carrageenan, a selective macrophage blocker, markedly reduced the anti-infectious effect of PSPG.
Adlam C, Broughton ES, Scott MT. Enhanced resistance of mice to infection with bacteria following pretreatment withCorynebacterium parvum. Nature (New Biol) 1972; 235: 219–20.
Collins FM, Scott MT. Effect ofCorynebacterium parvum treatment on the growth ofSalmonella enteritidis in mice. Infect Immun 1974; 9: 863–9.
Miyata H, Nomoto K, Takeya K. Characteristics of resistance toListeria monocytogenes enhanced byCorynebacterium parvum in mice. Immunology 1980; 40: 33–9.
Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, Yoshikai Y, Nomoto K. Augmentation of host resistance toListeria monocytogenes infection byLactobacillus casei. J Clin Lab Immunol 1985; 17: 91–7.
Nomoto K, Miake S, Yokokura T, Shimizu T, Mutai M, Nomoto K. Systemic augmentation of host defense mechanism by subcutaneous administration ofLactobacillus casei in mice. J Clin Lab Immunol 1985; 18: 43–8.
Miake S, Nomoto K, Yokokura T, Mutai M, Nomoto K. Protective effect ofLactobacillus casei onPseudomonas aeruginosa infection in mice. Infect Immun 1985; 48: 480–5.
Nagaoka M, Kamisango K, Fujii H, Uchikawa K, Sekikawa I, Azuma I. Structure of acidic polysaccharide from cell wall ofPropionibacterium acnes strain C7. J Biochem 1985; 97: 1669–78.
Galleli A, Garrec YL, Chedid L. Increased resistance and depressed delayed-type hypersensitivity toListeria monocytogenes induced by pretreatment with lipopolysaccharide. Infect Immun 1981; 31: 88–94.
Parant M, Parant F, Chedid L. Enhancement of resistance to infections by endotoxin-induced serum factor fromMycobacterium bovis BCG-infected mice. Infect Immun 1980; 28: 654–9.
Chedid L, Parant M, Parant F, Lefrancier P, Choay J, Lederer E. Enhancement of nonspecific immunity toKlebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs. Proc Natl Acad Sci USA 1977; 74: 2089–93.
Fraser-Smith EB, Matthews TR. Protective effect of muramyl dipeptide analogs against infections ofPseudomonas aeruginosa orCandida albicans in mice. Infect Immun 1981; 34: 676–83.
Osada Y, Mitsuyama M, Une T, Matsumoto K, Otani T, Satoh M, Ogawa H, Nomoto K. Effect of L18-MDP (Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections. Infect Immun 1982; 37: 292–300.
Chedid L, Parant M, Parant F, Audibert F, Lefrancier F, Choay J, Sela M. Enhancement of certain biological activities of muramyl dipeptide derivatives after conjugation to a multi-poly (DL-alanine)-poly (L-lysine) carrier. Proc Natl Acad Sci USA 1979; 76: 6557–61.
Finger H, Von Konig CHW. Failutre of synthetic muramyl dipeptide to increase antibacterial resistance. Infect Immun 1980; 27: 288–91.
Humphers RC, Henika PR, Ferraresi RW, Krahenbuhl JL. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance toListeria monocytogenes in mice. Infect Immun 1980; 30: 462–6.
Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 1972; 407-77.
Catanzaro PJ, Schwartz HJ, Graham RC. Spectrum and possible mechanism of carrageenan cytotoxicity. Amer J Pathol 1971; 64: 387–404.
Rumjanek VM, Watson SR, Sljivic VS. A re-evaluation of the role of macrophages in carrageenan-induced immunosuppression. Immunology 1977; 33: 423–32.
Mitsuyama M, Takeya K, Nomoto K, Shimotori S. Three phase of phagocyte contribution to resistance againstListeria monocytogenes. J Gen Microbiol 1978; 106: 165–71.
Yoshikai Y, Miake S, Mitsuyama M, Nomoto K. Effects ofCorynebacterium parvum onEscherichia coli infection in mice. J Gen Microbiol 1982; 128: 2857–63.
Sham Lal, Mitsuyama M, Ogata N, Miyata M, Miake S, Nomoto K. BCG-induced susceptibility of mice to challenge withPseudomonas aeruginosa. J Gen Microbiol 1982; 128: 93–8.
Peavy DL, Baughn RE, Muscher DM. Effects of BCG infection on the susceptibility of mouse macrophage to endotoxin. Infect Immun 1979; 24: 59–64.
Suter E. Hyperreactivity to endotoxin after infection with BCG. Studies on its distinguishing properties. J Immunol 1964; 92: 49–54.
Yoshikai Y, Miake S, Sano M, Nomoto K. Increased susceptibility toEscherichia coli infection in mice pretreated withCorynebacterium parvum. Microbiol Immunol 1983; 27: 273–82.
- Augmentation of resistance of mice to bacterial infection by a polysaccharide-peptidoglycan complex (PSPG) extracted fromLactobacillus casei
Volume 1, Issue 3 , pp 169-177
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- Lactobacillus casei
- polysaccharide-peptidoglycan complex (PSPG)
- bacterial infection